Provention Bio, Inc.
(NASDAQ GS: PRVB)
Rigrodsky Law, P.A. is investigating Provention Bio, Inc. (“Provention”) regarding possible breaches of fiduciary duties and other violations of law related to Provention’s agreement to be acquired by Sanofi. Under the terms of the agreement, Provention’s shareholders will receive $25.00 in cash per share.